Research - Seoul, , South Korea
MD Healthcare Inc. is a microbiome-based precision medicine venture established in Seoul, South Korea in 2014. We have conducted metagenomic analysis of tens of thousands of clinical samples and found that microbial extracellular vesicles (EVs) are powerful biomarkers for disease diagnosis and potent therapeutic agents. Using our proprietary microbial EV postbiotic technology, we are developing a variety of drug pipelines, diagnostic kits, and personalized healthcare services. By harnessing our microbial EV technology, we are developing pre-clinical core drug pipelines for immuno-oncology, respiratory, GI, skin, and CNS disease treatment in addition to AI-driven non-invasive diagnostic tools for various chronic diseases.
Apache
Google Tag Manager
OpenSSL
Mobile Friendly
JQuery 1.11.1